Sachdev Ulka, Baril Donald T, Ellozy Sharif H, Lookstein Robert A, Silverberg Daniel, Jacobs Tikva S, Carroccio Alfio, Teodorescu Victoria J, Marin Michael L
Division of Vascular Surgery, Department of Surgery, Mount Sinai Medical Center, New York, NY 10029, USA.
J Vasc Surg. 2006 Oct;44(4):718-24. doi: 10.1016/j.jvs.2006.06.027.
Aneurysms involving branches of the superior mesenteric and celiac arteries are uncommon and require proper management to prevent rupture and death. This study compares surgical and endovascular treatment of these aneurysms and analyzes outcome.
Patients at the Mount Sinai Medical Center in New York who were treated for aneurysms in the branches of the celiac artery and superior mesenteric artery were identified through a search of the institution's medical records and endovascular database. Patient demographics, history, clinical presentation, aneurysm characteristics, treatments, and follow-up outcome were retrospectively recorded. Significant differences between patients treated by surgical or endovascular therapy were determined by using Student's t test and chi2 analysis.
Between January 1, 1991, and July 1, 2005, 59 patients with 61 aneurysms were treated at a single institution. Twenty-four patients had surgical repair, and 35 underwent endovascular treatment, which included coil embolization and stent-graft therapy. Splenic (28) and hepatic (22) artery aneurysms predominated. Eighty-nine percent of splenic artery aneurysms were true aneurysms and were treated by endovascular and surgical procedures in near equal numbers (14 and 11, respectively). Pseudoaneurysms were significantly more likely to be treated by endovascular means (P < .01). The technical success rate of endovascular treatment for aneurysms was 89%, and failures were successfully treated by repeat coil embolization in all patients who presented for retreatment. Patients treated by endovascular techniques had a significantly higher incidence of malignancy than patients treated with open surgical techniques (P = .03). Furthermore, patients treated by endovascular means had a shorter in-hospital length of stay (2.4 vs 6.6 days, P < .001).
Endovascular management of visceral aneurysms is an effective means of treating aneurysms involving branches of the celiac and superior mesenteric arteries and is particularly useful in patients with comorbidities, including cancer. It is associated with a decreased length of stay in the elective setting, and failure of primary treatment can often be successfully managed percutaneously.
累及肠系膜上动脉和腹腔干动脉分支的动脉瘤并不常见,需要恰当的处理以防止破裂和死亡。本研究比较了这些动脉瘤的手术治疗和血管内治疗,并分析其结果。
通过检索纽约西奈山医学中心的医疗记录和血管内数据库,确定该中心接受腹腔干动脉和肠系膜上动脉分支动脉瘤治疗的患者。回顾性记录患者的人口统计学资料、病史、临床表现、动脉瘤特征、治疗方法及随访结果。采用Student t检验和卡方分析确定手术治疗或血管内治疗患者之间的显著差异。
1991年1月1日至2005年7月1日期间,一家机构共治疗了59例患者的61个动脉瘤。24例患者接受了手术修复,35例接受了血管内治疗,包括弹簧圈栓塞和支架移植物治疗。以脾动脉(28个)和肝动脉(22个)动脉瘤为主。89%的脾动脉动脉瘤为真性动脉瘤,接受血管内治疗和手术治疗的数量相近(分别为14个和11个)。假性动脉瘤更有可能采用血管内治疗(P < .01)。动脉瘤血管内治疗的技术成功率为89%,所有接受再次治疗的患者经重复弹簧圈栓塞均成功治疗失败病例。与接受开放手术治疗的患者相比,接受血管内技术治疗的患者恶性肿瘤发生率显著更高(P = .03)。此外,接受血管内治疗的患者住院时间更短(2.4天对6.6天,P < .001)。
内脏动脉瘤的血管内治疗是治疗累及腹腔干和肠系膜上动脉分支动脉瘤的有效方法,对包括癌症在内的合并症患者尤其有用。在择期情况下,它与住院时间缩短相关,且初次治疗失败通常可经皮成功处理。